AstraZeneca

ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer

WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …

ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer Read More


AstraZeneca

MATTERHORN Trial Reveals Promising Results for Early Gastric Cancer Treatment

WILMINGTON, DE — The Phase III MATTERHORN trial has delivered groundbreaking results, demonstrating that AstraZeneca’s IMFINZI® (durvalumab) combined with FLOT chemotherapy significantly improves outcomes for patients with resectable early-stage and …

MATTERHORN Trial Reveals Promising Results for Early Gastric Cancer Treatment Read More


Woman checking blood pressure of a man

Chester County’s Health Crisis Unveiled: Urgent Call to Action for a Stronger, Healthier Future

WEST CHESTER, PA — The Chester County Health Department has unveiled its latest Community Health Assessment (CHA), offering a comprehensive overview of the health and wellness of county residents. The …

Chester County’s Health Crisis Unveiled: Urgent Call to Action for a Stronger, Healthier Future Read More